The U.S. pledged $19.8 million toward initial development of a vaccine under a contract that could reach $312 million, according to the article.
Takeda, based in Japan, told The Wall Street Journal the Japanese government, with which it is working on fighting pandemic influenza, could join the Zika vaccine efforts.
Other companies are also trying to develop a Zika vaccine, including French drugmaker Sanofi.
More articles on healthcare quality:
Leading global hand hygiene experts to publish handbook for hospitals
Trinity Health, 21 hepatitis C outbreak victims reach settlement
VA to offer hepatitis C drugs to all veterans in its system: 6 things to know
